These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 9409331

  • 21. Influence of natural antioxidants on in vitro lipoprotein oxidation.
    Dobreanu M, Módy E.
    Rom J Intern Med; 1997; 35(1-4):55-62. PubMed ID: 9562653
    [Abstract] [Full Text] [Related]

  • 22. Oxidative modification and antioxidant protection of human low density lipoprotein at high and low oxygen partial pressures.
    Hatta A, Frei B.
    J Lipid Res; 1995 Nov; 36(11):2383-93. PubMed ID: 8656076
    [Abstract] [Full Text] [Related]

  • 23. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B.
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms by which cysteine can inhibit or promote the oxidation of low density lipoprotein by copper.
    Patterson RA, Lamb DJ, Leake DS.
    Atherosclerosis; 2003 Jul; 169(1):87-94. PubMed ID: 12860254
    [Abstract] [Full Text] [Related]

  • 25. Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.
    Meyer DF, Mayans MO, Groot PH, Suckling KE, Bruckdorfer KR, Perkins SJ.
    Biochem J; 1995 Sep 01; 310 ( Pt 2)(Pt 2):417-26. PubMed ID: 7654177
    [Abstract] [Full Text] [Related]

  • 26. Mangostin inhibits the oxidative modification of human low density lipoprotein.
    Williams P, Ongsakul M, Proudfoot J, Croft K, Beilin L.
    Free Radic Res; 1995 Aug 01; 23(2):175-84. PubMed ID: 7581813
    [Abstract] [Full Text] [Related]

  • 27. The kinetics of copper-induced LDL oxidation depend upon its lipid composition and antioxidant content.
    Visioli F, Bordone R, Perugini C, Bagnati M, Cau C, Bellomo G.
    Biochem Biophys Res Commun; 2000 Feb 24; 268(3):818-22. PubMed ID: 10679289
    [Abstract] [Full Text] [Related]

  • 28. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein.
    Retsky KL, Frei B.
    Biochim Biophys Acta; 1995 Aug 03; 1257(3):279-87. PubMed ID: 7647104
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of low-density lipoprotein oxidation by carnosine histidine.
    Decker EA, Ivanov V, Zhu BZ, Frei B.
    J Agric Food Chem; 2001 Jan 03; 49(1):511-6. PubMed ID: 11305256
    [Abstract] [Full Text] [Related]

  • 31. Prooxidant and antioxidant properties of Trolox C, analogue of vitamin E, in oxidation of low-density lipoprotein.
    Albertini R, Abuja PM.
    Free Radic Res; 1999 Mar 03; 30(3):181-8. PubMed ID: 10711788
    [Abstract] [Full Text] [Related]

  • 32. Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu2+-mediated oxidative modification of human low density lipoproteins.
    Yeomans VC, Linseisen J, Wolfram G.
    Eur J Nutr; 2005 Oct 03; 44(7):422-8. PubMed ID: 15827683
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of copper- and peroxyl radical-induced LDL lipid oxidation by ebselen: antioxidant actions in addition to hydroperoxide-reducing activity.
    Lass A, Witting P, Stocker R, Esterbauer H.
    Biochim Biophys Acta; 1996 Sep 27; 1303(2):111-8. PubMed ID: 8856040
    [Abstract] [Full Text] [Related]

  • 34. Antioxidant and pro-oxidant effects of epinephrine and isoprenaline on peroxidation of LDL and lipid liposomes.
    Ondrias K, Stasko A, Gergel D, Hromadová M, Misík V.
    Physiol Res; 1998 Sep 27; 47(2):119-24. PubMed ID: 9706995
    [Abstract] [Full Text] [Related]

  • 35. Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro.
    Brown JE, Rice-Evans CA.
    Free Radic Res; 1998 Sep 27; 29(3):247-55. PubMed ID: 9802556
    [Abstract] [Full Text] [Related]

  • 36. Modification of the lipid-protein interaction in human low-density lipoprotein destabilizes ApoB-100 and decreases oxidizability.
    Abuja PM, Lohner K, Prassl R.
    Biochemistry; 1999 Mar 16; 38(11):3401-8. PubMed ID: 10079085
    [Abstract] [Full Text] [Related]

  • 37. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation.
    Belinky PA, Aviram M, Fuhrman B, Rosenblat M, Vaya J.
    Atherosclerosis; 1998 Mar 16; 137(1):49-61. PubMed ID: 9568736
    [Abstract] [Full Text] [Related]

  • 38. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals.
    Noguchi N, Gotoh N, Niki E.
    Biochim Biophys Acta; 1994 Jul 14; 1213(2):176-82. PubMed ID: 8025128
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
    Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G.
    Biochem J; 1999 May 15; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.